D.E. Shaw & Co’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-67,636
| Closed | -$8.92M | – | 4113 |
|
|
2018
Q4 | $8.92M | Sell |
67,636
-45,325
| -40% | -$5.81M | 0.01% | 1167 |
|
|
2018
Q3 | $15.1M | Buy |
+112,961
| New | +$16.9M | 0.02% | 906 |
|
|
2018
Q1 | – | Sell |
-18,471
| Closed | -$2.46M | – | 3920 |
|
|
2017
Q4 | $2.46M | Sell |
18,471
-112,562
| -86% | -$14.4M | ﹤0.01% | 1986 |
|
|
2017
Q3 | $16.3M | Sell |
131,033
-24,045
| -16% | -$3.31M | 0.03% | 704 |
|
|
2017
Q2 | $21.8M | Buy |
+155,078
| New | +$19.4M | 0.04% | 559 |
|
|
2016
Q3 | – | Sell |
-48,241
| Closed | -$6.66M | – | 3657 |
|
|
2016
Q2 | $6.66M | Sell |
48,241
-54,043
| -53% | -$7.15M | 0.01% | 1118 |
|
|
2016
Q1 | $14.2M | Sell |
102,284
-4,687
| -4% | -$643K | 0.03% | 679 |
|
|
2015
Q4 | $17.2M | Buy |
+106,971
| New | +$16.5M | 0.03% | 703 |
|
|
2015
Q3 | – | Sell |
-5,295
| Closed | -$691K | – | 4019 |
|
|
2015
Q2 | $607K | Sell |
5,295
-31,519
| -86% | -$3.77M | ﹤0.01% | 3051 |
|
|
2015
Q1 | $4.39M | Buy |
36,814
+31,078
| +542% | +$4.14M | 0.01% | 1469 |
|
|
2014
Q4 | $836K | Buy |
+5,736
| New | +$720K | ﹤0.01% | 2963 |
|
|
2014
Q1 | – | Sell |
-2,370
| Closed | -$390K | – | 4800 |
|
|
2013
Q4 | $319K | Buy |
+2,370
| New | +$305K | ﹤0.01% | 4030 |
|
|
2013
Q3 | – | Sell |
-5,539
| Closed | -$599K | – | 4544 |
|
|
2013
Q2 | $469K | Buy |
+5,539
| New | +$496K | ﹤0.01% | 3292 |
|
D.E. Shaw & Co's ATHN Position: Q1 2019 in Review
D.E. Shaw & Co sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 67,636 shares — an estimated $8.92M sold.
D.E. Shaw & Co first reported a position in ATHN in Q2 2013 and held it in 13 quarters. The position peaked at $21.8M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- D.E. Shaw & Co reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- D.E. Shaw & Co sold 67,636 Athenahealth, Inc. shares in Q1 2019, an estimated $8.92M.
- D.E. Shaw & Co first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 13 quarters.
- D.E. Shaw & Co's Athenahealth, Inc. position peaked at $21.8M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.